These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39262720)

  • 1. NCKAP1 as a prognostic and immunological biomarker: pan-cancer analysis and validation in renal clear cell carcinoma.
    Liang X; Hong A; Shen R; Zhu M; Tian W
    Am J Transl Res; 2024; 16(8):4083-4100. PubMed ID: 39262720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker.
    Zhang D; Liang P; Xia B; Wu J; Hu X
    BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma.
    Zhu A; Zong Y; Wei S; Li Y; Fan Y; Liu S; Gao X
    J Cancer; 2023; 14(17):3351-3367. PubMed ID: 37928421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma.
    Chen J; Ge J; Zhang W; Xie X; Zhong X; Tang S
    Front Genet; 2022; 13():764957. PubMed ID: 35957696
    [No Abstract]   [Full Text] [Related]  

  • 6. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer.
    Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M
    Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma.
    Xia QD; Li B; Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhang SH; Zhong XY; Zeng N; Ma SY; He HD; Zhang YC; Guan W; Li H; Wang SG
    Front Oncol; 2023; 13():1096341. PubMed ID: 37035135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma.
    Lin Y; Chen R; Jiang M; Hu B; Zheng P; Chen G
    Oncol Lett; 2023 Sep; 26(3):379. PubMed ID: 37559574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
    Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
    Front Genet; 2023; 14():1109991. PubMed ID: 36992705
    [No Abstract]   [Full Text] [Related]  

  • 14. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
    Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
    Front Genet; 2022; 13():978840. PubMed ID: 36186442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma.
    Somsuan K; Aluksanasuwan S
    Genomics Inform; 2023 Jun; 21(2):e22. PubMed ID: 37423640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
    Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
    Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of
    Liu W; Xiao Z; Dong M; Li X; Huang Z
    Oncol Lett; 2024 Mar; 27(3):97. PubMed ID: 38288038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma.
    Wang K; Chen X; Liu Y; Meng X; Zhou L
    Transl Cancer Res; 2024 Jul; 13(7):3536-3555. PubMed ID: 39145091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of expression profiles and prognostic significance for MMDS-related iron-sulfur proteins in renal clear cell carcinoma.
    Yang L; Chen YX; Li YY; Liu XJ; Jiang YM; Mai J
    Sci Rep; 2022 Nov; 12(1):19637. PubMed ID: 36385109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
    Ju Q; Li XM; Zhang H; Zhao YJ
    Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.